Zobrazeno 1 - 7
of 7
pro vyhledávání: '"hiPSC, human induced pluripotent stem cells"'
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 3, Pp 315-338 (2020)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
An understanding of the molecular basis of liver regeneration will open new horizons for the development of novel therapies for chronic liver failure. Such therapies would solve the drawbacks associated with liver transplant, including the shortage o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57f94c2b2aed8589dc105db85be58c0
http://www.sciencedirect.com/science/article/pii/S2542454820300394
http://www.sciencedirect.com/science/article/pii/S2542454820300394
Autor:
Hidekazu Sekine, Minoru Ono, Akitoshi Inui, Kazunori Sano, Eiji Kobayashi, Katsuhisa Matsuura, Tatsuya Shimizu, Izumi Dobashi, Azumi Yoshida
Publikováno v:
Regenerative Therapy
Regenerative Therapy, Vol 11, Iss, Pp 316-323 (2019)
Regenerative Therapy, Vol 11, Iss, Pp 316-323 (2019)
Introduction: The definitive treatment for severe heart failure is transplantation. However, only a small number of heart transplants are performed each year due to donor shortages. Therefore, novel treatment approaches based on artificial organs or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14c41939ddc7dfbd2a5dabc9c5c21c1
http://europepmc.org/articles/PMC6818334
http://europepmc.org/articles/PMC6818334
Autor:
Bärbel M. Ulmer, Thomas Eschenhagen
Publikováno v:
Biochimica et Biophysica Acta. Molecular Cell Research
Cardiomyocyte energy metabolism is altered in heart failure, and primary defects of metabolic pathways can cause heart failure. Studying cardiac energetics in rodent models has principal shortcomings, raising the question to which extent human induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71276d0c8da9d21adba0857ccad1822a
https://pubmed.ncbi.nlm.nih.gov/30954570
https://pubmed.ncbi.nlm.nih.gov/30954570
Autor:
Peter Sartipy, Caroline Améen, Yalda Bogestål, Sandra Holmgren, Anders Lindahl, Jane Synnergren, Gustav Holmgren, Karolina Åkesson
Publikováno v:
Toxicology
Doxorubicin is a chemotherapeutic agent indicated for the treatment of a variety of cancer types, including leukaemia, lymphomas, and many solid tumours. The use of doxorubicin is, however, associated with severe cardiotoxicity, often resulting in ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1e0e372506a93b30d215e5e4bc63ab
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-11417
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-11417
Autor:
Abu Rmilah AA; Division of Transplantation Surgery, Mayo Clinic, Rochester, MN., Zhou W; Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.; First Affiliated Hospital of China, Medical University, Department of Hepatobiliary Surgery, Shenyang, China., Nyberg SL; Division of Transplantation Surgery, Mayo Clinic, Rochester, MN.
Publikováno v:
Mayo Clinic proceedings. Innovations, quality & outcomes [Mayo Clin Proc Innov Qual Outcomes] 2020 Jun 05; Vol. 4 (3), pp. 315-338. Date of Electronic Publication: 2020 Jun 05 (Print Publication: 2020).
Autor:
Inui A; Department of Cardiac Surgery, University of Tokyo, Tokyo, Japan., Sekine H; Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan., Sano K; Tokaihit Co., Ltd., Shizuoka, Japan., Dobashi I; Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan., Yoshida A; Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan., Matsuura K; Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan., Kobayashi E; Department of Organ Fabrication, Keio University School of Medicine, Tokyo, Japan., Ono M; Department of Cardiac Surgery, University of Tokyo, Tokyo, Japan., Shimizu T; Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.
Publikováno v:
Regenerative therapy [Regen Ther] 2019 Oct 22; Vol. 11, pp. 316-323. Date of Electronic Publication: 2019 Oct 22 (Print Publication: 2019).
Autor:
Latour YL; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA., Yoon R; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA., Thomas SE; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA., Grant C; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA., Li C; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA., Sena-Esteves M; Department of Neurology and Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605, USA., Allende ML; Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Proia RL; Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Tifft CJ; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Molecular genetics and metabolism reports [Mol Genet Metab Rep] 2019 Sep 11; Vol. 21, pp. 100513. Date of Electronic Publication: 2019 Sep 11 (Print Publication: 2019).